Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W3GE
|
|||
| Former ID |
DNCL003265
|
|||
| Drug Name |
Plague vaccine
|
|||
| Indication | leukaemia [ICD-11: 2A60-2B33] | Phase 2 | [1] | |
| Yersinia infection [ICD-11: 1B93] | Phase 2 | [1] | ||
| Company |
DynPort Vaccine
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01122784) Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.